ID23858A - SULFATE SALT FROM AN HIV PROTEASE INHIBITOR THAT HAS ORAL ABSORPTION OF BIODIVERSITY THAT IS IMPROVED - Google Patents
SULFATE SALT FROM AN HIV PROTEASE INHIBITOR THAT HAS ORAL ABSORPTION OF BIODIVERSITY THAT IS IMPROVEDInfo
- Publication number
- ID23858A ID23858A IDW991462A ID991462A ID23858A ID 23858 A ID23858 A ID 23858A ID W991462 A IDW991462 A ID W991462A ID 991462 A ID991462 A ID 991462A ID 23858 A ID23858 A ID 23858A
- Authority
- ID
- Indonesia
- Prior art keywords
- biodiversity
- improved
- protease inhibitor
- hiv protease
- sulfate salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23858A true ID23858A (en) | 2000-05-25 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991462A ID23858A (en) | 1997-05-29 | 1998-05-26 | SULFATE SALT FROM AN HIV PROTEASE INHIBITOR THAT HAS ORAL ABSORPTION OF BIODIVERSITY THAT IS IMPROVED |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (en) |
| JP (1) | JP3267632B2 (en) |
| KR (1) | KR20010013042A (en) |
| CN (1) | CN1257497A (en) |
| AU (1) | AU730245B2 (en) |
| BG (1) | BG103923A (en) |
| BR (1) | BR9809498A (en) |
| CA (1) | CA2291086A1 (en) |
| EA (1) | EA199901095A1 (en) |
| EE (1) | EE9900543A (en) |
| HR (1) | HRP980283A2 (en) |
| HU (1) | HUP0004621A3 (en) |
| ID (1) | ID23858A (en) |
| IL (1) | IL132779A0 (en) |
| IS (1) | IS5240A (en) |
| NO (1) | NO995822L (en) |
| PE (1) | PE75099A1 (en) |
| PL (1) | PL336847A1 (en) |
| SK (1) | SK163299A3 (en) |
| TR (1) | TR199902816T2 (en) |
| TW (1) | TW438799B (en) |
| WO (1) | WO1998054178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514910A (en) * | 1999-11-24 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | Gamma-hydroxy-2- (fluoroalkylaminocarbonyl) -1-piperazinepentanamides as HIV protease inhibitors |
| WO2002022582A2 (en) * | 2000-09-14 | 2002-03-21 | Ortho-Mcneil Pharmaceutical, Inc. | Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ278201A (en) * | 1993-12-15 | 1998-01-26 | Merck & Co Inc | Bicyclic heterocyclically substituted piperazine derivatives as hiv protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/en active
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/en unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/en unknown
- 1998-05-26 PL PL98336847A patent/PL336847A1/en unknown
- 1998-05-26 EE EEP199900543A patent/EE9900543A/en unknown
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 IL IL13277998A patent/IL132779A0/en unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/en not_active Application Discontinuation
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/en not_active Application Discontinuation
- 1998-05-26 JP JP50079999A patent/JP3267632B2/en not_active Expired - Fee Related
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 CN CN98805372A patent/CN1257497A/en active Pending
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/en unknown
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 SK SK1632-99A patent/SK163299A3/en unknown
- 1998-05-26 EA EA199901095A patent/EA199901095A1/en unknown
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-28 PE PE1998000432A patent/PE75099A1/en not_active Application Discontinuation
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/en not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/en unknown
- 1999-11-24 BG BG103923A patent/BG103923A/en unknown
- 1999-11-26 NO NO995822A patent/NO995822L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998054178A1 (en) | 1998-12-03 |
| KR20010013042A (en) | 2001-02-26 |
| BG103923A (en) | 2000-06-30 |
| HRP980283A2 (en) | 1999-08-31 |
| IL132779A0 (en) | 2001-03-19 |
| NO995822D0 (en) | 1999-11-26 |
| HUP0004621A2 (en) | 2002-03-28 |
| NO995822L (en) | 2000-01-28 |
| SK163299A3 (en) | 2000-07-11 |
| AU7595998A (en) | 1998-12-30 |
| EE9900543A (en) | 2000-06-15 |
| EA199901095A1 (en) | 2000-08-28 |
| PL336847A1 (en) | 2000-07-17 |
| CN1257497A (en) | 2000-06-21 |
| TW438799B (en) | 2001-06-07 |
| BR9809498A (en) | 2000-06-20 |
| CA2291086A1 (en) | 1998-12-03 |
| TR199902816T2 (en) | 2000-02-21 |
| PE75099A1 (en) | 1999-08-11 |
| EP0986554A1 (en) | 2000-03-22 |
| JP2000513747A (en) | 2000-10-17 |
| HUP0004621A3 (en) | 2002-04-29 |
| IS5240A (en) | 1999-11-09 |
| JP3267632B2 (en) | 2002-03-18 |
| AU730245B2 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID25921A (en) | SULFONAMIDES FOR TREATMENT OF ENDOTELIN DISEASES | |
| DE60101968D1 (en) | ALPHA CRYSTAL SHAPE OF PERINDOPRILE TERT BUTYLAMINE SALT | |
| DK1056722T3 (en) | Hydrogen sulfate salt of HIV protease inhibitor | |
| DE69926714D1 (en) | Reduction of resource consumption by ACD systems | |
| PT1086076E (en) | SULFONAMIDE INHIBITORS OF ASPARTIL PROTEASE | |
| DE60033859D1 (en) | Inhibitor of respiratory syncytial virus | |
| NO20023582D0 (en) | Asymmetric synthesis of pregabalin | |
| ID24053A (en) | ASSOCIATION OF CONNECTION WHICH CAN BE REMOVED FOR PUNCHING AGAIN | |
| DE10194333T1 (en) | Method of quantum computing | |
| NO20005265D0 (en) | Substituted benzamides, their preparation and use as inhibitors of cystine proteases | |
| ID23130A (en) | ONLY WEARS OF DIAPERS THAT HAVE MECHANICAL RICHES | |
| EA200201175A1 (en) | USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF ATHEROSCLEROSIS | |
| FR2825920B1 (en) | DESFERAL AS INHIBITOR OF NO-SYNTHASE AND USES | |
| DE60103877T2 (en) | REMOVAL OF SODIUM CHLORIDE FROM PHOSPHONOMETHYLIMINODIACETIC ACID PROCESS | |
| ID30158A (en) | THIOUREA THAT CONTAIN HETEROSICLIC OF CARBOXAMIDE, PREVENTION OF HERPES VIRUSES CONTAINING PHENILENADIAMINE CLUSTERS | |
| ID23858A (en) | SULFATE SALT FROM AN HIV PROTEASE INHIBITOR THAT HAS ORAL ABSORPTION OF BIODIVERSITY THAT IS IMPROVED | |
| DE60031450D1 (en) | POLYMORPH V OF TORASEMID | |
| ITMI20010004A0 (en) | PROCEDURE FOR CONTROLLING A JTAG INTERFACE OF A MICROPROCESSOR OF A MICROCONTROLLER ON WHICH A JTAG AND M INTERFACE IS IMPLEMENTED | |
| EE200200227A (en) | Type 1 Crystals of Sodium Hydrogen Ion Inhibitor | |
| ID24344A (en) | PURIFICATION OF OXIDA PROPILENA | |
| ID27712A (en) | ABSORBEN WHICH IS FORMED (FROM P004950) | |
| GB0105046D0 (en) | Purification of amphoteric surfactants | |
| EG24065A (en) | Monohydrate of cis-lithium-4-cyano-4-(3-cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate | |
| KR19990008090U (en) | Integral outlet formed of elastic member | |
| KR960037418U (en) | Chiller of water purifier |